Literature DB >> 9556352

Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry.

K Tsuneyama1, J Van De Water, K Yamazaki, K Suzuki, S Sato, Y Takeda, B Ruebner, B A Yost, Y Nakanuma, R L Coppel, M E Gershwin.   

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune liver disease of unknown etiology. Nearly 93% of patients with PBC exhibit evidence of focal sialoadenitis. In an earlier study, we reported evidence of aberrant expression of PDC-E2, or a mimeotope, in the salivary glands of patients with PBC that had Sjogren's syndrome. At the time of the previous study, data was not yet available regarding patients with PBC without sicca complaints. Therefore, to investigate the extent of salivary gland involvement in PBC, we collected lip biopsy sections from 9 PBC patients diagnosed as PBC by liver biopsy, without clinical or histologic features of Sjogren's syndrome and 9 PBC patients with established Sjogren's syndrome. Using immunohistochemical staining with both a murine monoclonal antibody. C355.1, and a human combinatorial antibody, SP4, we examined the ducts of these salivary glands for the presence of the characteristic aberrant staining pattern found in patients with PBC. We report that 6/9 PBC patients fulfilling established Sjogren's syndrome criteria and 6/9 PBC patients lacking features of Sjogren's syndrome showed intense staining of the ductal epithelial cells of the salivary gland. These data suggest that the PBC-specific antigen recognized by C355.1 and SP4 in bile duct epithelial cells is expressed aberrantly in the salivary gland in 66% of patients with PBC, independent of Sjogren's syndrome. This finding suggests a common disease process in these two tissues. Further, expression of this molecule may be an early marker of salivary gland involvement in patients with PBC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9556352     DOI: 10.3109/08916939709009547

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

1.  T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis.

Authors:  Jorge Allina; Bin Hu; Daniel M Sullivan; Maria Isabel Fiel; Swan N Thung; Steven F Bronk; Robert C Huebert; Judy van de Water; Nicholas F LaRusso; M E Gershwin; Gregory J Gores; Joseph A Odin
Journal:  J Autoimmun       Date:  2007-01-10       Impact factor: 7.094

Review 2.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 3.  Diagnosis and treatment of xerostomia (dry mouth).

Authors:  Joel J Napeñas; Michael T Brennan; Philip C Fox
Journal:  Odontology       Date:  2009-07-29       Impact factor: 2.634

Review 4.  Primary biliary cirrhosis is a generalized autoimmune epithelitis.

Authors:  Jun Gao; Liang Qiao; Bingyuan Wang
Journal:  Int J Mol Sci       Date:  2015-03-20       Impact factor: 5.923

5.  Systemic mononuclear inflammatory vasculopathy associated with Sjögren's syndrome in a patient with primary biliary cirrhosis.

Authors:  J K Min; K S Park; W J Yu; Y S Lee; S M Park; S H Park; C S Cho; H Y Kim
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.